FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Animals : an open access journal from MDPI2024; 14(23); 3406; doi: 10.3390/ani14233406

A Pilot Study to Assess the Safety and Efficacy of Umbilical Cord Blood-Derived Mesenchymal Stromal Cells for the Treatment of Synovitis in Horses.

Abstract: Synovitis is present before and during osteoarthritis in horses and can result in performance-limiting lameness. Twenty-four horses with lameness localized to the metacarpo-/metatarsophalangeal joint or a single joint of the carpus were enrolled in this study. We evaluated the response of intra-articular injection with 10 million activated (aMSC) or non-activated (naMSC) allogeneic equine umbilical cord blood-derived mesenchymal stromal cells (MSCs). Subjective and objective lameness was assessed on Days 0, 1, 21, and 42. The treatment injection was randomly assigned and performed following the baseline assessment on Day 0. naMSC-treated horses had straight-line lameness scores that were significantly lower on Day 21 (1.0 ± 1.15) and Day 42 (1.13 ± 1.00) than on Day 0 ( = 0.0098 and = 0.0418, respectively). aMSC-treated horses had straight-line lameness scores that were significantly lower on Day 21 (0.96 ± 1.03) and Day 42 (0.79 ± 1.05) than on Day 0 ( = 0.0011 and < 0.0001, respectively). There was no significant difference between the treatment groups for any parameter at any timepoint. In conclusion, both aMSC and naMSC allogeneic MSCs resulted in significantly improved subjective lameness scores in horses when compared to baseline lameness scores.
Get Full Text
Publication Date: 2024-11-26 PubMed ID: 39682372PubMed Central: PMC11640105DOI: 10.3390/ani14233406Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research evaluates whether the injection of activated and non-activated mesenchymal stromal cells derived from horse umbilical cord blood can help reduce lameness caused by synovitis in horses.

Study Design and Participants

  • The study was conducted on 24 horses suffering from lameness localized to the metacarpo-/metatarsophalangeal joint or a single joint of the carpus. The lameness was a result of synovitis, a condition that can lead to osteoarthritis and greatly affect the horse’s performance.
  • The treatment for every horse was determined randomly and was administered after an initial assessment on Day 0.

Treatments and Measurements

  • The researchers used two types of mesenchymal stromal cells (MSCs), one type was activated (aMSC), and the other type was non-activated (naMSC).
  • 10 million of these cells were injected intra-articularly (inside the affected joint) into the horses.
  • The efficacy of the treatment was evaluated based on the changes in the horses’ lameness. Objective and subjective lameness assessments were carried out on Days 0, 1, 21, and 42 from the start of the treatment.

Treatment Results

  • The naMSC treatment resulted in significantly lower lameness scores on Day 21 and Day 42, as compared to Day 0.
  • The aMSC treatment also caused a significant decrease in lameness scores on Day 21 and Day 42 from Day 0.
  • There was no significant difference observed between the effects of the aMSC treatment and the naMSC treatment at any given point in time.

Conclusions

  • The study concluded that both activated and non-activated allogeneic MSCs decreased the lameness scores in horses, indicating an improvement in their condition.
  • The results suggest the safety and efficacy of these cells in treating synovitis in horses, presenting a potential treatment option for dealing with this condition.

Cite This Article

APA
Seabaugh K, Rao S, Koenig JB, Pezzanite L, Dow S, Koch TG, Russell KA, Mehrpouyan S, Alizadeh AH, Goodrich LR. (2024). A Pilot Study to Assess the Safety and Efficacy of Umbilical Cord Blood-Derived Mesenchymal Stromal Cells for the Treatment of Synovitis in Horses. Animals (Basel), 14(23), 3406. https://doi.org/10.3390/ani14233406

Publication

Animals : an open access journal from MDPI
ISSN: 2076-2615
NlmUniqueID: 101635614
Country: Switzerland
Language: English
Volume: 14
Issue: 23
PII: 3406

Researcher Affiliations

Seabaugh, Kathryn
  • Orthopaedic Research Center, Translational Medicine Institute, Colorado State University, Fort Collins, CO 80523, USA.
Rao, Sangeeta
  • Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
Koenig, Judith B
  • Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, ON N1G2W1, Canada.
Pezzanite, Lynn
  • Orthopaedic Research Center, Translational Medicine Institute, Colorado State University, Fort Collins, CO 80523, USA.
  • Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
Dow, Steven
  • Orthopaedic Research Center, Translational Medicine Institute, Colorado State University, Fort Collins, CO 80523, USA.
  • Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
Koch, Thomas G
  • eQcell Inc., University of Guelph, 50 Stone Road East, Guelph, ON N1G 2W1, Canada.
Russell, Keith A
  • eQcell Inc., University of Guelph, 50 Stone Road East, Guelph, ON N1G 2W1, Canada.
Mehrpouyan, Sahar
  • eQcell Inc., University of Guelph, 50 Stone Road East, Guelph, ON N1G 2W1, Canada.
Alizadeh, A Hamed
  • eQcell Inc., University of Guelph, 50 Stone Road East, Guelph, ON N1G 2W1, Canada.
Goodrich, Laurie R
  • Orthopaedic Research Center, Translational Medicine Institute, Colorado State University, Fort Collins, CO 80523, USA.

Grant Funding

  • na / eQcell, Inc

Conflict of Interest Statement

Koch is the Founder and CEO of eQcell and a member of eQcell’s Board of Directors and Scientific Advisory Board. Russell, Mehrpouyan, and Alizadeh are eQcell employees. Goodrich, Dow, and Koenig are members of the Scientific Advisory Board for eQcell, Inc., and Goodrich is a Shareholder in eQcell, Inc. The remaining authors declare no conflicts of interest. The funders of this project, eQcell, Inc., did play a role in the design of this study, in that they chose the two treatments and provided the treatments free of charge. eQcell had no role in the collection, analysis, or interpretation of data or the decision to publish the results.

References

This article includes 21 references
  1. Vishwanath K, Secor EJ, Watkins A, Reesink HL, Bonassar LJ. Loss of Effective Lubricating Viscosity Is the Primary Mechanical Marker of Joint Inflammation in Equine Synovitis. J. Orthop. Res. 2024;42:1438–1447.
    doi: 10.1002/jor.25793pubmed: 38291343google scholar: lookup
  2. Bertoni L, Jacquet-Guibon S, Branly T, Desancé M, Legendre F, Melin M, Rivory P, Hartmann DJ, Schmutz A, Denoix JM. Evaluation of Allogeneic Bone-Marrow-Derived and Umbilical Cord Blood-Derived Mesenchymal Stem Cells to Prevent the Development of Osteoarthritis in An Equine Model. Int. J. Mol. Sci. 2021;22:2499.
    doi: 10.3390/ijms22052499pmc: PMC7958841pubmed: 33801461google scholar: lookup
  3. Colbath AC, Dow SW, McIlwraith CW, Goodrich LR. Mesenchymal Stem Cells for Treatment of Musculoskeletal Disease in Horses: Relative Merits of Allogeneic Versus Autologous Stem Cells. Equine Vet. J. 2020;52:654–663.
    doi: 10.1111/evj.13233pubmed: 31971273google scholar: lookup
  4. Pezzanite LM, Chow L, Johnson V, Griffenhagen GM, Goodrich L, Dow S. Toll-Like Receptor Activation of Equine Mesenchymal Stromal Cells to Enhance Antibacterial Activity and Immunomodulatory Cytokine Secretion. Vet. Surg. 2021;50:858–871.
    doi: 10.1111/vsu.13628pubmed: 33797775google scholar: lookup
  5. Pezzanite LM, Chow L, Phillips J, Griffenhagen GM, Moore AR, Schaer TP, Engiles JB, Werpy N, Gilbertie J, Schnabel LV. TLR-Activated Mesenchymal Stromal Cell Therapy and Antibiotics to Treat Multi-Drug Resistant Staphylococcal Septic Arthritis in an Equine Model. Ann. Transl. Med. 2022;10:1157.
    doi: 10.21037/atm-22-1746pmc: PMC9708491pubmed: 36467344google scholar: lookup
  6. Kester W. Guide for Veterinary Services and Judging of Equestrian Events. American Association of Equine Practioners; Lexington, KY, USA: 1991. Definition and classification of lameness; p. 19.
  7. Koch TG, Heerkens T, Thomsen PD, Betts DH. Isolation of Mesenchymal Stem Cells from Equine Umbilical Cord Blood. BMC Biotechnol. 2007;7:26.
    doi: 10.1186/1472-6750-7-26pmc: PMC1904213pubmed: 17537254google scholar: lookup
  8. Bogers SH. Cell-Based Therapies for Joint Disease in Veterinary Medicine: What We Have Learned and What We Need to Know. Front. Vet. Sci. 2018;5:70.
    doi: 10.3389/fvets.2018.00070pmc: PMC5911772pubmed: 29713634google scholar: lookup
  9. Frisbie D.D. Stem Cells. In: McIlwraith C.W., Frisbie D.D., Kawcak C.E., van Weeren R., editors. Joint Disease in the Horse. Elsevier Health Sciences; St. Louis, MO, USA: 2015.
  10. Agung M, Ochi M, Yanada S, Adachi N, Izuta Y, Yamasaki T, Toda K. Mobilization of Bone Marrow-Derived Mesenchymal Stem Cells into the Injured Tissues after Intraarticular Injection and Their Contribution to Tissue Regeneration. Knee Surg. Sports Traumatol. Arthrosc. 2006;14:1307–1314.
    doi: 10.1007/s00167-006-0124-8pubmed: 16788809google scholar: lookup
  11. Ossendorff R, Walter SG, Schildberg FA, Khoury M, Salzmann GM. Controversies in Regenerative Medicine: Should Knee Joint Osteoarthritis Be Treated with Mesenchymal Stromal Cells?. Eur. Cell Mater. 2022;43:98–111.
    doi: 10.22203/eCM.v043a09pubmed: 35298024google scholar: lookup
  12. Zhang X, He J, Wang W. Progress in the Use of Mesenchymal Stromal Cells for Osteoarthritis Treatment. Cytotherapy. 2021;23:459–470.
    doi: 10.1016/j.jcyt.2021.01.008pubmed: 33736933google scholar: lookup
  13. Molnar V, Pavelic E, Vrdoljak K, Cemerin M, Klaric E, Matisic V, Bjelica R, Brlek P, Kovacic I, Tremolada C. Mesenchymal Stem Cell Mechanisms of Action and Clinical Effects in Osteoarthritis: A Narrative Review. Genes. 2022;13:949.
    doi: 10.3390/genes13060949pmc: PMC9222975pubmed: 35741711google scholar: lookup
  14. Broeckx SY, Seys B, Suls M, Vandenberghe A, Marien T, Adriaensen E, Declercq J, Van Hecke L, Braun G, Hellmann K. Equine Allogeneic Chondrogenic Induced Mesenchymal Stem Cells Are an Effective Treatment for Degenerative Joint Disease in Horses. Stem Cells Dev. 2019;28:410–422.
    doi: 10.1089/scd.2018.0061pmc: PMC6441287pubmed: 30623737google scholar: lookup
  15. Punzon E, Salguero R, Totusaus X, Mesa-Sanchez C, Badiella L, Garcia-Castillo M, Pradera A. Equine Umbilical Cord Mesenchymal Stem Cells Demonstrate Safety and Efficacy in the Treatment of Canine Osteoarthritis: A Randomized Placebo-Controlled Trial. J. Am. Vet. Med. Assoc. 2022;260:1947–1955.
    doi: 10.2460/javma.22.06.0237pubmed: 36198051google scholar: lookup
  16. Olsson DC, Teixeira BL, Jeremias TDS, Réus JC, Canto GDL, Porporatti AL, Trentin AG. Administration of Mesenchymal Stem Cells from Adipose Tissue at the Hip Joint of Dogs with Osteoarthritis: A Systematic Review. Res. Vet. Sci. 2021;135:495–503.
    doi: 10.1016/j.rvsc.2020.11.014pubmed: 33280823google scholar: lookup
  17. Kriston-Pal E, Haracska L, Cooper P, Kiss-Toth E, Szukacsov V, Monostori E. A Regenerative Approach to Canine Osteoarthritis Using Allogeneic, Adipose-Derived Mesenchymal Stem Cells. Safety Results of a Long-Term Follow-Up. Front. Vet. Sci. 2020;7:510.
    doi: 10.3389/fvets.2020.00510pmc: PMC7438407pubmed: 32903517google scholar: lookup
  18. Knott LE, Fonseca-Martinez BA, O’Connor AM, Goodrich LR, McIlwraith CW, Colbath AC. Current Use of Biologic Therapies for Musculoskeletal Disease: A Survey of Board-Certified Equine Specialists. Vet. Surg. 2022;51:557–567.
    doi: 10.1111/vsu.13805pmc: PMC9322007pubmed: 35383972google scholar: lookup
  19. Donnell JR, Frisbie DD, King MR, Goodrich LR, Haussler KK. Comparison of Subjective Lameness Evaluation, Force Platforms and an Inertial-Sensor System to Identify Mild Lameness in an Equine Osteoarthritis Model. Vet. J. 2015;206:136–142.
    doi: 10.1016/j.tvjl.2015.08.004pubmed: 26361749google scholar: lookup
  20. Wu MJ, Zhao K, Fils-Aime F. Response Rates of Online Surveys in Published Research: A Meta-Analysis. Comput. Hum. Behav. Rep. 2022;7:100206.
    doi: 10.1016/j.chbr.2022.100206google scholar: lookup
  21. Adams LR, Munoz KA. Owner Survey Suggests Cats May Be Undertreated for Pain Compared to Dogs After an Elective Ovariohysterectomy or Orchiectomy. Am. J. Vet. Res. 2024;85:1–8.
    doi: 10.2460/ajvr.24.03.0055pubmed: 38710204google scholar: lookup

Citations

This article has been cited 0 times.
Subscribe to our newsletter
Join 100,113 horse owners like you who receive our email updates on horse health and nutrition.